Investigación / Grupos de investigación

Grupo  2

Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Publicaciones (571)

  • Diaz-Ruiz, R; Poca, M; Roman, E; Panadero-Gomez, R; Cuyàs, B; Bañares, I; Morales, A; Puerto, M; Lopez-Esteban, R; Blazquez, E; Fernández-Castillo, M; Correa-Rocha, R; Rapado-Castro, M; Breton, I; Bañares, R; Soriano, G; Garcia-Martinez, R.

    Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis

    Nutrients. 2025; 17(2): Nº de citas: 1 [doi:10.3390/nu17020226]

  • Albillos, A; Bañares, R; Hernández-Gea, V.

    Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd)

    Gastroenterologia y Hepatologia. 2025; 48(1): [doi:10.1016/j.gastrohep.2024.502208]

  • Olivera, PA; Martinez-Lozano, H; Leibovitzh, H; Xue, MY; Neustaeter, A; Espin-Garcia, O; Xu, W; Madsen, KL; Guttman, DS; Bernstein, CN; Yerushalmi, B; Hyams, JS; Abreu, MT; Marshall, JK; Wrobel, I; Mack, DR; Jacobson, K; Bitton, A; Aumais, G; Panacionne, R; Dieleman, LA; Silverberg, MS; Steinhart, AH; Moayyedi, P; Turner, D; Griffiths, AM; Turpin, W; Lee, SH; Croitoru, K.

    Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease

    GASTROENTEROLOGY. 2025; 168(1): Nº de citas: 6 [doi:10.1053/j.gastro.2024.08.031]

  • Lamas-Paz, A; Hionides-Gutierrez, A; Guo, FF; Jorquera, G; Moran-Blanco, L; Benede-Ubieto, R; Mesquita, M; Estevez-Vazquez, O; Zheng, K; Mazariegos, M; Vazquez-Ogando, E; Blazquez-Lopez, E; Asensio, I; Mutlu, B; Gomez-Santos, B; Peligros, MI; Vaquero, J; Banares, R; Delgado, TC; Martinez-Chantar, ML; Martinez-Naves, E; Sanz-Garcia, C; Mohamed, MR; Tesolato, S; Iniesta, P; Gallego-Duran, R; Maya-Miles, D; Ampuero, J; Romero-Gomez, M; Martinez-Alcocer, A; Sanfeliu-Redondo, D; Fernandez-Iglesias, A; Gracia-Sancho, J; Coll, M; Graupera, I; Gines, P; Ciudin, A; Rivera-Esteban, J; Pericas, JM; Avila, MA; Frutos, MD; Martinez-Caceres, CM; Ramos-Molina, B; Aspichueta, P; Puigserver, P; Nevzorova, YA; Cubero, FJ.

    Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis

    Jhep Reports. 2025; 7(1): Nº de citas: 1 [doi:10.1016/j.jhepr.2024.101230]

  • Virseda-Berdices, A; Martín-Escolano, R; Berenguer, J; González-García, J; Brochado-Kith, O; Rojo, D; Díez, C; Hontañon, V; Pérez-Latorre, L; Ibañez-Samaniego, L; Llop-Herrera, E; Olveira, A; Fernández-Rodríguez, A; Barbas, C; Resino, S; Jimenez-Sousa, MA; ESCORIAL Study Grp.

    Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients

    LIVER INTERNATIONAL. 2025; 45(1): [doi:10.1111/liv.16204]

  • Ortega Lobete O; Pérez Garvin A; Payeras Otero I; Nogales Rincón Ó.

    Digestive pseuodpolyposis as a form of presentation of digestive metastases of primary gastric leiomyosarcoma.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2025; 117(1): 58-59 [doi:10.17235/reed.2023.9626/2023]

  • Benedé-Ubieto, R; Cubero, FJ; Nevzorova, YA.

    Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

    Gut Microbes. 2024; 16(1): Nº de citas: 72 [doi:10.1080/19490976.2024.2331460]

  • Gisbert, JP; Donday, MG; Riestra, S; Lucendo, AJ; Benitez, JM; Navarro-Llavat, M; Barrio, J; Morales-Alvarado, VJ; Rivero, M; Busquets, D; Carnerero, EL; Merino, O; Castillejo, ON; Navarro, P; Van Domselaar, M; Gutierrez, A; Alonso-Abreu, I; Mejuto, R; Fernandez-Salazar, L; Iborra, M; Martin-Arranz, MD; Pineda, JR; Sampedro, MJ; Nilsson, KS; Bouhmidi, A; Batista, L; Villafranca, CM; Rodriguez-Lago, I; Ceballos, D; Guerra, I; Manosa, M; Jimenez, IM; Torrella, E; Mendoza, MV; Casanova, MJ; de Francisco, R; Arias-Gonzalez, L; Pedrosa, SM; Garcia-Bosch, O; Garcia-Alonso, FJ; Delgado-Guillena, P; Garcia, MJ; Torrealba, L; Nunez-Ortiz, A; Arregui, MV; Bosca-Watts, MM; Blazquez, I; Acosta, D; Garre, A; Baldan, M; Martinez, C; Acosta, MBD; Domenech, E; Esteve, M; Garcia-Sanchez, V; Nos, P; Panes, J; Chaparro, M.

    Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU

    GUT. 2024; 74(3): Nº de citas: 6 [doi:10.1136/gutjnl-2024-333385]

  • Segura, PS; Gomollón, F; Casas, D; Iborra, M; Vela, M; Fernández-Clotet, A; Muñoz, R; de la Filia, IG; Prada, MG; Rosique, JAF; García, MJ; de Francisco, R; Arias, L; Barrio, J; Guerra, I; Ponferrada, A; Gisbert, JP; Carrillo-Palau, M; Calvet, X; Márquez-Mosquera, L; Gros, B; Cañete, F; Monfort, D; Domínguez, REM; Roncero, O; Laredo, V; Montoro, M; Muñoz, C; López-Cauce, B; Lorente, R; Coronel, AF; Vega, P; Martín, D; Peña, E; Varela, P; Olivares, S; Pajares, R; Lucendo, AJ; Sesé, E; Mateu, BB; Nos, P; Domènech, E; García-López, S.

    Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study

    DIGESTIVE AND LIVER DISEASE. 2024; 56(12): 2060-2068 Nº de citas: 1 [doi:10.1016/j.dld.2024.05.021]

  • Caballero-Marcos, A; Rodríguez-Bachiller, L; Baroja-Mazo, A; Morales, A; Fernández-Cáceres, P; Fernández-Martínez, M; DíazFontenla, F; Velasco, E; Fernández-Yunquera, A; Díaz-Zorita, B; Cortese, S; Pérez-Peña, JM; Colón-Rodríguez, A; Romero-Cristóbal, M; Asencio, JM; Bañares, R; López-Baena, JA; Salcedo-Plaza, M.

    Dynamics of Ischemia/Reperfusion Injury Markers During Normothermic Liver Machine Perfusion

    Transplantation Direct. 2024; 10(12): Nº de citas: 2 [doi:10.1097/TXD.0000000000001728]

  • Perez-Campuzano, V; Rautou, PE; Marjot, T; Praktiknjo, M; Alvarado-Tapias, E; Turco, L; Ibáñez-Samaniego, L; González-Alayón, C; Puente, A; Llop, E; Simón-Talero, M; álvarez-Navascués, C; Reiberger, T; Verhelst, X; Tellez, L; Bergmann, JB; Orts, L; Grassi, G; Baiges, A; Audrey, P; Trebicka, J; Villanueva, C; Morelli, MC; Murray, S; Meacham, G; Luetgehetmann, M; Wiesch, JSZ; García-Pagán, JC; Barnes, E; Plessier, A; Hernández-Gea, V.

    Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

    Jhep Reports. 2024; 6(12): Nº de citas: 1 [doi:10.1016/j.jhepr.2024.101191]

  • Sánchez, AR; Tamargo, FGP; Carbonell-Blanco, C; Vazquez-Sequeros, E; Lucas, D.

    Double-snare resection technique: a new approach for treating rectal carcinoid tumors

    ENDOSCOPY. 2024; 56: 454-455 Nº de citas: 1 [doi:10.1055/a-2318-2645]

  • Hionides-Gutierrez, A; Goikoetxea-Usandizaga, N; Sanz-Garcia, C; Martinez-Chantar, ML; Cubero, FJ.

    Novel Emerging Mechanisms in Acetaminophen (APAP) Hepatotoxicity

    LIVER INTERNATIONAL. 2024; 45(4): Nº de citas: 4 [doi:10.1111/liv.16167]

  • Islam AH; Díaz LA; Idalsoaga F; Guizzetti L; Mortuza R; Dunn W; Singal AK; Simonetto D; Ramirez-Cadiz C; Zhang W; Qian S; Cabezas J; Sarin SK; Maiwall R; Jalal PK; Higuera-De La Tijera F; Skladany L; Bystrianska N; Rincon D; Chacko KR; Ventura Cots M; Garcia-Tsao G; Abraldes JG; Kamath PS; Arrese M; Shah V; Bataller R; Arab JP.

    Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis.

    Hepatology Communications. 2024; 8(11): [doi:10.1097/HC9.0000000000000573]

  • Gargallo-Puyuelo CJ; Ricart E; Iglesias E; de Francisco R; Gisbert JP; Taxonera C; Mañosa M; Aguas Peris M; Navarrete-Muñoz EM; Sanahuja A; Guardiola J; Mesonero F; Rivero Tirado M; Barrio J; Vera Mendoza I; de Castro Parga L; García-Planella E; Calvet X; Martín Arranz MD; García S; Sicilia B; Carpio D; Domenech E; Gomollón F.

    Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA.

    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024; 22(11): 2280-2290 Nº de citas: 6 [doi:10.1016/j.cgh.2024.05.013]

  • Casanova, MJ; Caballol, B; García, MJ; Mesonero, F; de Célix, CR; Suárez-Alvarez, P; Ferreiro-Iglesias, R; Martín-Rodríguez, MDM; de Francisco, R; Varela-Trastoy, P; Bastida, G; Carrillo-Palau, M; Núñez-Ortiz, A; Ramírez-de la Piscina, P; Ceballos, D; Hervías-Cruz, D; Muñoz-Pérez, R; Velayos, B; Bermejo, F; Busquets, D; Cabacino, M; Camo-Monterde, P; Marín-Jiménez, I; Muñoz, C; de la Peña-Negro, LC; Sierra-Moros, E; Barrio, J; Brunet-Mas, E; Bujanda, L; Cañete, F; Gomollón, F; Manceñido-Marcos, N; Rodríguez-Lago, I; Rodríguez-Grau, MC; Sicilia, B; Torra-Alsina, S; Arranz-Hernández, L; Carpio, D; García-Sepulcre, MF; González-Muñoza, C; Huguet, JM; Márquez-Mosquera, L; López-Serrano, MP; Ponferrada-Díaz, A; Chaparro, M; Gisbert, JP.

    Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

    DIGESTIVE AND LIVER DISEASE. 2024; 56(11): 1845-1853 Nº de citas: 4 [doi:10.1016/j.dld.2024.05.009]

  • Cortese, S; Plua, K; Perez-Alonso, AJ; Hontoria, MS; Pacheco, D; Carroll, NZ; Gómez, MAB; Pena, JMP; Taboada, AGM; Martinez, MF; Kakauridze, SH; Matilla, AM; Baena, JAL; Asencio, JM.

    Internal and external validation of indocyanine green plasma disappearance rate to discard liver grafts before procurement

    Annals Of Hepato-Biliary-Pancreatic Surgery. 2024; 28(4): 458-465 [doi:10.14701/ahbps.24-086]

  • Paternostro, R; Kwanten, WJ; Hofer, BS; Semmler, G; Bagdadi, A; Luzko, I; Hernández-Gea, V; Graupera, I; García-Pagán, JC; Saltini, D; Indulti, F; Schepis, F; Moga, L; Rautou, PE; Llop, E; Téllez, L; Albillos, A; Fortea, JI; Puente, A; Tosetti, G; Primignani, M; Zipprich, A; Vuille-Lessard, E; Berzigotti, A; Taru, MG; Taru, V; Procopet, B; Jansen, C; Praktiknjo, M; Gu, WY; Trebicka, J; Ibanez-Samaniego, L; Bañares, R; Rivera-Esteban, J; Pericas, JM; Genesca, J; Alvarado, E; Villanueva, C; Larrue, H; Bureau, C; Laleman, W; Ardevol, A; Masnou, H; Vanwolleghem, T; Trauner, M; Mandorfer, M; Francque, S; Reiberger, T.

    Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

    JOURNAL OF HEPATOLOGY. 2024; 81(5): Nº de citas: 21 [doi:10.1016/j.jhep.2024.05.033]